Erbe Medical: Strengthening the Roots of Technological Excellence within Medical Sector

Rakesh Kundu, Managing Director

Rakesh Kundu

Managing Director

Amidst healthcare reforms and innovations happening in medical industry, technology’s clinical importance has paved its way wide and leaping towards developments that were nearly inconceivable before. The engineering brilliance embedded within technological innovations such as robotic surgery, wireless brain sensors, health wearables and many others, continues to improve medical industry, making it more cheaper, faster and highly efficient. Regulating engineering excellence in medical industry since 2007, Chennai-based Erbe Medical develops, manufactures and distributes surgical systems for professional medical usage and making innovation accessible worldwide.

A subsidiary of Erbe Elektromedizin GmbH, Erbe is highly recognized for its uniquely developed, quality products and the excellence it portrays in combining technologies to achieve a particular clinical outcome. While technical expertise is core to the company’s modus operandi, robust service network and workforce competence defines Erbe’s notable attributes, making it stand tall within the competitive ambit. Under the ace leadership of Rakesh Kundu (Managing Director), Erbe has managed to station expert service engineers in major cities and owns five service centres PAN India for efficient service delivery.

Comprehensive Portfolio
Erbe’s product portfolio includes various devices and instruments for electrosurgery, thermofusion, plasmasurgery, cryosurgery, hydrosurgery and hybrid surgery, amongst which the company’s quality products for electrosurgery are highly leveraged
worldwide. While Erbe’s specialized offerings for gastroenterology, pulmonology and general surgery are regarded gold standards globally, the company owns proprietary rights of technology it developed for hydrosurgery and cryosurgery. Be it offering advanced electro surgical generator for electro surgery, usable products for thermo fusion or instruments and hardware generators for plasma surgery, the company offers it all under one roof.

Each product developed, manufactured and distributed is FDA and BE approved, and owns all certifications testifying its superior quality output

Strictly adhering to all rules and regulations of European Union and Europe, Erbe manufacturers all its products with highest quality standards at Erbe’s sole manufacturing unit based in Germany. Each product developed, manufactured and distributed is FDA and BE approved, and owns all certifications testifying its superior quality output.

Team that Deploys Excellence
Unlike companies prioritizing product merchandising for profitable numbers, Erbe believes in having long term collaboration with its clients through prompt servicing. Besides, the company experts leave no stone unturned in having single point of contact with the customers and end users to generate awareness and have a certain reach for effective communication.

Erbe continuously engages in various training and academic programs and supports its personnel in undertaking various workshops and training sessions. Hence is the company’s engagement with various training centres and centre of excellence for providing specialized training and plans to establish Erbe Academy in India in future endeavours. “We utilize highly specialized skill to promote our products and train the newcomers,” adds Pranshu Abhishek, Marketing & Training Lead, Erbe Medical.

Innovative Strategies, Profound Prospects
Driven by a team of 50+ pros, Erbe records revenue growth in double digits and has received two consecutive awards for its growth excellence. Having branch offices in Delhi, Mumbai and Kolkata with presence PAN India, the company is advancing towards innovation and has blueprints ready for launching new product for pulmonology and varied solutions for both pulmonology and gastroenterology. “The industry is forecasting newer opportunities. With corporate hospitals expanding their chains and building new infrastructure, it is a positive indicator for us to come up with new products and strategies for penetrating and gaining market share. Our strategy is to go deep and broad in terms of collaborations and distribution reach,” concludes Rakesh.